Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation

NCT02893176 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT02893176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02893176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Withdrawn
Start date
September 30, 2016
Completion date
September 19, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant rejection